PLEOTREATMENT Trademark

Trademark Overview


On Wednesday, September 4, 2013, a trademark application was filed for PLEOTREATMENT with the United States Patent and Trademark Office. The USPTO has given the PLEOTREATMENT trademark a serial number of 79142345. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, September 3, 2023. This trademark is owned by PHARNEXT. The PLEOTREATMENT trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Training services in the field of medicine and clinical trials; publishing writing and publication of books and texts other than advertising texts; non-downloadable electronic publication of texts in the nature of articles, magazines, brochures in the field of online medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions, seminars in the field of medicine; teaching in the field of medicine and clinical trials

Creation, compilation, management of databases and central data files in the field of medicine and clinical trials Database management, collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics; compilation and systematization of data into a central file; public relations; business information, namely, provision of commercial information in the fields of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials

Medical services; pharmacy advice; Providing information about the diagnosis and treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, and awareness and information regarding the treatment regarding the aforementioned diseases and illnesses

Pharmaceutical research and development; scientific research for medical purposes in the field of medicine and clinical trials; Scientific and clinical research studies in the fields of medicine, the prevention, treatment and management of illness, health care delivery; chemical and biological analysis, research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; research on chemical reagents for medical use, namely, biomarkers
pleotreatment

General Information


Serial Number79142345
Word MarkPLEOTREATMENT
Filing DateWednesday, September 4, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, September 3, 2023
Registration Number4661507
Registration DateTuesday, December 30, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 14, 2014

Trademark Statements


Goods and ServicesTraining services in the field of medicine and clinical trials; publishing writing and publication of books and texts other than advertising texts; non-downloadable electronic publication of texts in the nature of articles, magazines, brochures in the field of online medicine; educational services, namely, organization and conducting of colloquiums, conferences, conventions, seminars in the field of medicine; teaching in the field of medicine and clinical trials
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCreation, compilation, management of databases and central data files in the field of medicine and clinical trials Database management, collection and compilation of information into computer databases in the field of medicine and clinical trials; compilation of statistics; compilation and systematization of data into a central file; public relations; business information, namely, provision of commercial information in the fields of pharmaceutical products and medical and scientific research in the field of pharmaceutical products and clinical trials
Translation of Words in MarkThe wording "PLEOTREATMENT" has no meaning in a foreign language.
Goods and ServicesMedical services; pharmacy advice; Providing information about the diagnosis and treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, medicines, namely, medicines for the treatment of neurological diseases, Charcot-Mary-Tooth disease, Alzheimer's disease, Parkinson's disease, idiopathic neuropathy, diabetic neuropathy, toxic neuropathy, amyothrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and metabolic disease including diabetes type II, and awareness and information regarding the treatment regarding the aforementioned diseases and illnesses
Goods and ServicesPharmaceutical research and development; scientific research for medical purposes in the field of medicine and clinical trials; Scientific and clinical research studies in the fields of medicine, the prevention, treatment and management of illness, health care delivery; chemical and biological analysis, research in chemistry, cosmetology, biology, bacteriology, nutrition, biotechnology; biological research for the diagnosis, prevention and treatment of diabetes and obesity and any other illness; biological research services in the field of chemical, biological and pharmaceutical products; software design and development; scientific laboratory services; research on chemical reagents for medical use, namely, biomarkers

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 16, 2021
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 16, 2021
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 16, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHARNEXT
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NamePHARNEXT
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NamePHARNEXT
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Sunday, March 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 31, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, March 31, 2024DEATH OF INTERNATIONAL REGISTRATION
Monday, August 8, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, July 7, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, July 7, 2022INVALIDATION PROCESSED
Wednesday, March 16, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, July 16, 2021CANCELLED SECTION 71
Monday, December 30, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 7, 2017NEW REPRESENTATIVE AT IB RECEIVED
Thursday, June 8, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 26, 2017NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 8, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 1, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 1, 2015FINAL DISPOSITION PROCESSED
Monday, March 30, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 30, 2014REGISTERED-PRINCIPAL REGISTER
Friday, October 24, 2014NOTIFICATION PROCESSED BY IB
Tuesday, October 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 14, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 8, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 8, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 10, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 10, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 10, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, September 10, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, September 10, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, September 10, 2014EXAMINERS AMENDMENT -WRITTEN
Wednesday, September 3, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 3, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 27, 2014ASSIGNED TO LIE
Monday, August 25, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 31, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 31, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 14, 2014REFUSAL PROCESSED BY IB
Tuesday, February 25, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 25, 2014REFUSAL PROCESSED BY MPU
Tuesday, February 25, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 25, 2014APPLICATION FILING RECEIPT MAILED
Monday, February 24, 2014NON-FINAL ACTION WRITTEN
Friday, February 21, 2014ASSIGNED TO EXAMINER
Friday, February 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 19, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, February 17, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB